S. Douglas Sheldon
Oprichter bij ESP Equity Partners LLC
Profiel
Mr. S.
Douglas Sheldon is Partner at ESP Equity Partners LLC.
Prior to co-founding ESP in 2005, Mr. Sheldon co-founded ESP Pharma, Inc. a specialty pharmaceutical company recently sold to Protein Design Labs.
He was a partner at ESP Partners LLC, a healthcare consulting and investment firm, the predecessor to ESP Pharma.
Prior to co-founding ESP Partners LLC in 2000, he was Vice-President of Strategic Partnership Development at Parke-Davis Pharmaceuticals where he co-founded an internal business accelerator that focused on the company's largest, revenue-generating products.
Mr. Sheldon began his career with Pfizer, Inc. and spent nearly 17 years working in senior international finance, marketing, country management and regional line management assignments in both South America and Asia.
In 1994, he founded Indochina Healthcare, joint venture operations in Thailand, Hong Kong, Vietnam and Myanmar, merging TTMC's existing hospital products business in orthopedics and urology with Mayne Pharma's (formerly F.H.
Faulding, Australia) oncology and cardiovascular business.
Mr. Sheldon remains active as an Executive Director, and Chairman of the Board of IHL.
Mr. Sheldon received his BS in Chemistry from LeMoyne College and MBA from Syracuse University.
He served as a Lieutenant Commander in the U.S.
Navy in both active duty and the reserves.
Actieve functies van S. Douglas Sheldon
| Bedrijven | Functie | Begin |
|---|---|---|
ESP Equity Partners LLC
 ESP Equity Partners LLC Investment ManagersFinance Founded by in 2005 by Howard Weisman, S. Douglas Sheldon and Dr. Jeffery Z. Li, ESP Equity Partners (ESP) is a private equity firm located in Cedar Knolls, New Jersey with additional offices in Miami and Beijing. | Oprichter | 03-09-2009 |
Sofregen Medical, Inc.
 Sofregen Medical, Inc. BiotechnologyHealth Technology Sofregen Medical, Inc. develops innovative silk-based solutions for soft tissue defects. Its products: SERI silk derived surgical scaffold is knitted scaffold made from ultra-pure, sterile, silk-derived bioprotein that facilitates neovascularization and native tissue regeneration over time and Sofregen technology a silk derived material for medical application. The company was founded by Anh Hoang and Howard J. Weisman on May 19, 2014 and is headquartered in Cambridge, MA. | Directeur/Bestuurslid | 10-11-2016 |
| Indochina Healthcare Co. Ltd. | Voorzitter | - |
Eerdere bekende functies van S. Douglas Sheldon
| Bedrijven | Functie | Einde |
|---|---|---|
EKR Therapeutics, Inc.
 EKR Therapeutics, Inc. Hospital/Nursing ManagementHealth Services EKR Therapeutics, Inc. is a specialty pharmaceutical company focused on acquiring, developing and maximizing the potential utility of critical-care hospital products offering broader therapeutic options and greater control to improve in-patient care, speed recovery, and achieve optimal outcomes. Backed by the strength of its award winning management team, the dedication of its field force of product specialists and its commitment to excellence in customer service and medical education, EKR has been organized to be a class leader in commercializing products to address unmet and under-satisfied medical needs or to otherwise enhance the therapeutic value of acute-care products. | Directeur/Bestuurslid | 03-10-2012 |
ESP Pharma, Inc.
 ESP Pharma, Inc. Pharmaceuticals: MajorHealth Technology ESP Pharma, Inc. produces pharmaceutical products. The company used to produce drug for acute-care hospital use and these drugs include therapeutics for high blood pressure and angina; one product, IV Busulfex, is used to prepare myelogenous for leukemia patients for bone marrow transplants. The company formulates its products to be delivered intravenously or by injection when oral administration is impossible. The company was founded in April, 2002 and was headquartered in Edison, NJ | President | 02-01-2002 |
| Parke, Davis & Co. LLC | Corporate Officer/Principal | - |
| PFIZER, INC. | Corporate Officer/Principal | - |
Opleiding van S. Douglas Sheldon
| University of Essex | Undergraduate Degree |
| Syracuse University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Bedrijven in privébezit | 6 |
|---|---|
ESP Pharma, Inc.
ESP Pharma, Inc. Pharmaceuticals: MajorHealth Technology ESP Pharma, Inc. produces pharmaceutical products. The company used to produce drug for acute-care hospital use and these drugs include therapeutics for high blood pressure and angina; one product, IV Busulfex, is used to prepare myelogenous for leukemia patients for bone marrow transplants. The company formulates its products to be delivered intravenously or by injection when oral administration is impossible. The company was founded in April, 2002 and was headquartered in Edison, NJ | Health Technology |
ESP Equity Partners LLC
ESP Equity Partners LLC Investment ManagersFinance Founded by in 2005 by Howard Weisman, S. Douglas Sheldon and Dr. Jeffery Z. Li, ESP Equity Partners (ESP) is a private equity firm located in Cedar Knolls, New Jersey with additional offices in Miami and Beijing. | Finance |
EKR Therapeutics, Inc.
EKR Therapeutics, Inc. Hospital/Nursing ManagementHealth Services EKR Therapeutics, Inc. is a specialty pharmaceutical company focused on acquiring, developing and maximizing the potential utility of critical-care hospital products offering broader therapeutic options and greater control to improve in-patient care, speed recovery, and achieve optimal outcomes. Backed by the strength of its award winning management team, the dedication of its field force of product specialists and its commitment to excellence in customer service and medical education, EKR has been organized to be a class leader in commercializing products to address unmet and under-satisfied medical needs or to otherwise enhance the therapeutic value of acute-care products. | Health Services |
| Parke, Davis & Co. LLC | |
Sofregen Medical, Inc.
Sofregen Medical, Inc. BiotechnologyHealth Technology Sofregen Medical, Inc. develops innovative silk-based solutions for soft tissue defects. Its products: SERI silk derived surgical scaffold is knitted scaffold made from ultra-pure, sterile, silk-derived bioprotein that facilitates neovascularization and native tissue regeneration over time and Sofregen technology a silk derived material for medical application. The company was founded by Anh Hoang and Howard J. Weisman on May 19, 2014 and is headquartered in Cambridge, MA. | Health Technology |
| Indochina Healthcare Co. Ltd. |
